Friday, January 19, 2018

MediLeaf Leaf:TSX Time To Accumulate Before The Next Leg Up

Leaf is preparing for its turn to run up ... 
We have a small float of 94.8 Million shares vs other high flyer cannabis shares

because today CMED,ACB, rallied...LEAF IS OverDue To Rally Again!

The Two Underwriters will have a great deal to justify if they pay 26.50 per share and the price is at $24.10...I will predict that LEAF WILL RALLY BEYOND the $26.50 just because the underwriters NEED to justify $132.5-million raised at $26.50

The offering below is expected to close on or about Jan. 31, 2018,
2018-01-09 10:40 ET - News Release
Mr. Dennis Fong reports
MEDRELEAF CORP. ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED OFFERING
Medreleaf Corp. has entered into a revised agreement with a syndicate of underwriters co-led by Canaccord Genuity Corp. and GMP Securities LP, pursuant to which the underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of five million units of the company at a price of $26.50 per unit for aggregate gross proceeds of $132.5-million.
Each unit will consist of one common share and one-half of one common share purchase warrant of the company. Each warrant will be exercisable to acquire one common share of the company for a period of two years following the closing date of the offering at an exercise price of $34.50 per common share, subject to adjustment in certain events. In the event that the volume-weighted average trading price of the common shares for 10 consecutive trading days exceeds $51.75, the company shall have the right to accelerate the expiry date of the warrants upon notice of not less than 15 trading days.

Aphria Picked As The Next Big Winner


Which Marijuana Stock Is the Better Buy: Aphria Inc. or Canopy Growth Corp.?
Under the agreement, Aphria will pay up to $10-million in cash, with the remainder in shares based on a deemed price of $15.09 per share. “Adding one of Canada's most sought-after premium brands represents a major triumph for Aphria and our shareholders and firmly establishes our position as a ...
Google PlusFacebookTwitterFlag as irrelevant

Cannabis Wheaton Stock Goes High on Aphria Supply Deal
(TSXV:CBW), the world's first cannabis streaming company, announced Wednesday that it has inked an interim supply agreement with Aphria Inc. (TSX:APH). As per the agreement, Aphria will supply Wheaton's subsidiary Navisent Inc., created for establishing international distribution channels, with up ...
Google PlusFacebookTwitterFlag as irrelevant

Aphria (TSE:APH) Price Target Raised to C$25.00
Aphria logo Aphria (TSE:APH) had its target price hoisted by Pi Financial from C$14.00 to C$25.00 in a report released on Thursday, January 11th. Pi Financial's price target indicates a potential upside of 13.38% from the company's previous close. Separately, Canaccord Genuity increased their price ...
Google PlusFacebookTwitterFlag as irrelevant

DOJA Cannabis and Tokyo Smoke Announce Signing of Definitive Business Combination ...
Aphria Inc.'s ("Aphria") (TSX: APH) (OTCQB: APHQF) $10 million equity investment in Hiku, demonstrates Aphria's commitment to native BC cannabis and its leadership in the recreational market. Hiku looks forward to the opportunity to supply all Aphria's brands in Hiku-owned retail (where licensed and ...
Google PlusFacebookTwitterFlag as irrelevant

Clarus Securities Analysts Increase Earnings Estimates for Aphria Inc (APH)
Aphria Inc (TSE:APH) – Stock analysts at Clarus Securities increased their Q3 2018 earnings estimates for Aphria in a research note issued to investors on Tuesday. Clarus Securities analyst N. Atkinson now forecasts that the company will post earnings of $0.02 per share for the quarter, up from their ...
Google PlusFacebookTwitterFlag as irrelevant

Why Loblaw Companies Ltd. Might Have a Horrible 2018
In early December, the drugstore announced a deal with Aphria Inc. (TSX:APH) to sell pot online, and that could possibly open the door to marijuana eventually being sold in store. If successful, it may only be a matter of time before Loblaw decides to add pot to its retail stores (where it is legal to do so).

Friday, January 12, 2018

Wednesday, January 10, 2018

Canadian Business Says...Investors are delusional

Provincial buyers are going to want to deal with licensed producers that can supply large amount of product at low prices. At present the average price of medical marijuana is roughly $10 per gram. Some publicly traded companies have boasted that their all-in costs are in the range of  70 cents to $1.75 per gram which translates into profit margins of more than 80 per cent. However, we can expect provincial agencies will severely cut into these margins. The Ontario wine industry provides us with some idea of profit margins that LPs might reasonably expect. In a recent study on Ontario Wine and Grape Industry (2015), for large scale operations the profit margins are just under 15 per cent and in fact many smaller vineyards were posting losses.



Allan Gregory is a professor of economics at Queen’s University.
As the July deadline for the provinces to legalize marijuana approaches, the stock prices of Canadian publicly-traded weed producers have been on a tear. On Monday alone shares in Canopy Growth Corp., soared nearly 20 per cent. The surge in market value comes as firms try to position themselves with sufficient product to meet anticipated demand. But as these companies, some valued in the billions of dollars despite generating no profits, continue to attract starry-eyed investors, it’s worth examining what kind of opportunities will exist for these firms when provinces regulate retail pot sales. It is not difficult to predict profit margins will fall under regulation and that current market cap valuations are predicated on unrealistic expectations.
While there are some variations across provinces in their distribution plans for legalized marijuana, the largest two provinces, Ontario and Quebec, intend to have provincial run outlets modelled on their government-controlled alcohol sales. Indeed, the alcohol model gives us an important clue as to how the industry is likely to shake out—and why marijuana producers face tough times ahead. Keep in mind that there will still be online purchases and the proportional divide between physical store and e-commerce is unclear. Ontario with only a planned 150 outlets might give us an early indication as to online traffic. But let us consider the possible ramifications from only the government outlets.
The Ontario Liquor Control Board (LCBO) and Société des alcools du Québec (SAQ) effectively have a monopoly on the sales of most alcohol products in their respective provinces (with the exception of beer and some wine). The LCBO is one of the world’s largest buyers and demands much from its suppliers in terms of large quantities and price discounts. Minor producers, even in Ontario, who are unable to meet the demands of the LCBO must sell their products elsewhere.
Giant provincial alcohol buyers with market power drive tough bargains in terms of price and quantity which dissipates suppliers’ profits. Of course, having a virtual monopoly on the retail side has meant that these pricing discounts are rarely passed onto its customers. I see the same tactics for recreational marijuana. There is the false belief that the licensed producers (LPs) of marijuana will get the same price from the provinces they have enjoyed in the retail-based medical market business.  However, aggressive bulk buying by large provincial authorities will whittle the producer price down markedly.
Provincial buyers are going to want to deal with licensed producers that can supply large amount of product at low prices. At present the average price of medical marijuana is roughly $10 per gram. Some publicly traded companies have boasted that their all-in costs are in the range of  70 cents to $1.75 per gram which translates into profit margins of more than 80 per cent. However, we can expect provincial agencies will severely cut into these margins. The Ontario wine industry provides us with some idea of profit margins that LPs might reasonably expect. In a recent study on Ontario Wine and Grape Industry (2015), for large scale operations the profit margins are just under 15 per cent and in fact many smaller vineyards were posting losses.
Meanwhile at implementation this will likely mean only the largest producers will be entering into contract with the provincial authorities. The notion of boutique suppliers of cannabis will have to wait, just like craft beer producers waited in alcohol sales. Establishing reliable supply lines will dominate initially any gourmet pot considerations.
Will provinces favour producers in their own backyards? Of course they will. Just as Ontario has favoured its own wine industry and shelves mostly their products for the domestic lines in their stores, so will it be true for provincial distributors. For instance, if you are a cannabis producer hoping to sell in Canada’s biggest markets, you will likely need a physical grow-op in Ontario or Quebec. This means regional producers will face additional barriers to growth. At present only the government of New Brunswick has announced a commitment to Organigram, a Moncton-based producer, to buy five million grams a year. The company, which has seen its shares soar 31 per cent in value so far this year, estimates that deal will translate into a retail value of $40 million to $60 million. (At present, Organigram’s market value stands at $630 million.) Other provinces will soon follow suit I believe and strike distribution arrangements for local provincial growers.
As in many stock market interactions, the industry tells a rosy story of growth and opportunity. But I would suggest a careful recall of the dot com bubble offers a somber warning. Canopy Growth Corp. is currently valued at just over $7.5 billion yet loses about 12 cents a share. At the same time, Canadian Tire Corp. has a valuation of $11.5 billion and earns $10 a share—and pays a dividend yield of 2.14 per cent.  What company offers a better long-term investment?